Pharmaceutical Technology, Feb 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Feb 1, 2012
Articles
Strategies for Preferred-Provider Partnerships
By Patricia Van Arnum
The author examines recent examples of preferred-provider collaborations.
Case Studies in Pharmaceutical Project Management
By Patricia Van Arnum
A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.
Managing the Quality Relationship for a Contractual Agreement
By Susan J. Schniepp
The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.
Evaluating Competitive Forces in Contract Manufacturing
By Patricia Van Arnum
The author examines the opportunities and positioning of contract service providers.
Outsourcing to Emerging Markets: The Effect of the European Economic Crisis
By Victor Coker
Each developing economy has unique economic, political, and cultural issues that help define its pharmaceutical market. To succeed, multinational pharmaceutical companies will have to adapt differently.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here